BLOOMIA HOLDINGS, INC. (TULP) stock intrinsic value fair value estimate & owner earnings analysis

Bloomia Holdings (formerly Lendway, and before that Insignia Systems) is now a single business: Bloomia, one of the largest growers of fresh-cut tulips in the United States, bought in February 2024 for about $47.5 million, largely with borrowed money. Bloomia buys bulbs in the Netherlands, Chile and New Zealand, grows them hydroponically in a leased 360,000 square-foot greenhouse in King George, Virginia (lease runs through 2028) and a smaller greenhouse near Cape Town, and sells about 90 million stems a year to roughly 40 U.S. retailers, mostly on the East Coast. Four mass-market retailers took 59% of sales in the year to June 2026 (20%, 18%, 11% and 10%). The company owns 81.4% of the operating subsidiary; Bloomia's chief executive owns the other 18.6%. Everything before 2024 describes an in-store advertising business that was sold in 2023 and tells us nothing about today's company. Earnings level. There are only two full years of tulip results. In the twelve months to June 2025 revenue was $48.4 million, gross margin 20.9%, and the business produced roughly $2 million a year of cash before interest after maintaining its equipment. In the year to June 2026 revenue was $48.1 million but gross margin fell to 16.4%: average bulb prices rose 21%, the euro rose 6%, a mite-control problem across the Dutch bulb industry caused what management estimates at more than $2.5 million of excess crop waste, and $1.5 million of tariffs were paid (refunded in July 2026). A 12% price increase held revenue flat on fewer stems. After a $600,000 one-time USDA grant, the year's cash before interest was about break-even, and owners' cash after interest was about -$2.1 million (-$0.85 per share). Adjusting for the waste, the tariffs and the grant points to the same ~$2 million a year normal level as the earlier year. Large non-cash items were excluded from cash earnings: an $11.1 million goodwill write-off and $2.0 million intangible write-off (management's own test found the business worth less than its book value), and a $7.0 million accounting gain from settling the sellers' note at a discount. Intangible amortization of about $1.5 million a year is added back; because those customer relationships wear out, no growth is credited and the later years fade. Debt. At June 30, 2026 the company owed about $24.0 million: a $13.95 million bank term loan (amortizing $450,000 a quarter, due February 2029), $4.0 million on the revolving credit line, a $2.67 million sellers' note accruing interest at rising rates (now in the low teens), a $1.0 million 11.5% note from a director-affiliated investor, $2.1 million of equipment finance leases and small machinery loans. Against this we credit the $1.5 million tariff refund received in July 2026; operating cash of $1.45 million is needed for a business that must pay about $14 million for bulbs between September 2026 and February 2027. The company breached its bank covenants at December 2025, March 2026 and June 2026 and received waivers each time. The September 2026 amendment raised the interest margin to as much as 5% over SOFR, keeps the revolver at $10 million only until May 31, 2027 (then $6 million, and Dutch inventory stops counting toward borrowing capacity), and charges $100,000 a month from February 2027 unless the bank debt is refinanced or $4 million of new capital is raised. Because this debt costs well above our benchmark for several years, we add about $2-3 million to the debt depending on the case. A spring 2026 rights offering at $4.05 a share converted $7.1 million of insider loans to equity and raised $5 million, which paid down the sellers' note; shares outstanding rose to about 4.83 million. Base case. The bulbs already contracted for the coming season are priced near 2025 levels and the company has invested in new mite treatment, so the first year improves to about $3.3 million of cash before interest; after that the business settles back at about $2.3 million a year, a little above the one clean year to reflect the price increase that has held, with no growth credited (all revenue growth to date came from buying Bloomia, not from a demonstrated expansion record). Beyond year ten earnings fade to zero over the following decade: the only structural advantage we can point to is that shipping bulbs by sea is cheaper than flying in cut stems, but margins are thin and concentrated retail buyers capture most of it. The business is worth about $22 million; with about $23.4 million owed at the operating subsidiary (including the above-market cost of the debt) and $1.0 million at the parent, the shares come to about -$0.44. In plain terms, in the middle case the company owes slightly more than the business is worth, and its roughly $2.3 million of cash before interest only just covers about $2.1-2.3 million of interest, leaving nothing to repay the $1.8 million a year of scheduled term-loan payments without further refinancing or new equity. Bear case. The company's own 2026 year is the downturn we use: a repeat of a bulb-price and currency spike and a disease-driven crop loss, here in years two and three, with cash before interest slightly negative each year, compounded by the loss of part of a 20% customer. The revolver shrinks to $6 million in May 2027 just as bulb purchases peak, so a second episode forces either a restructuring or heavily dilutive capital raised at distressed prices. Recovery afterward is only to about $1.5 million a year. The business is worth about $11 million against roughly $25.4 million of debt, so the company would owe about $14.6 million more than it is worth, about -$3.03 a share. Bull case. The levers already visible all work: contracted bulb prices return cost per stem to 2025 levels, the 12% price increase largely sticks, and the new mite treatment removes the excess waste. Applying those to the 2026 cost base gives about $6 million of cash before interest in the first year and about $4.5 million thereafter, and the bank debt is refinanced at ordinary rates. The business is worth about $44 million; after about $22.4 million of subsidiary debt, the 18.6% minority share and the parent's $1.0 million note, the shares are worth about $3.43. What changed since our previous analysis. The September 2026 annual report gave the first complete fiscal year under the new June year-end: margins and cash flow were worse than the nine-month figures suggested, management wrote off all goodwill and part of the brand value, and the bank tightened terms and set a refinancing deadline. On the other side, the coming season's bulbs are contracted at lower prices and the tariffs were refunded. Earlier figures were also prepared on a different basis and are not directly comparable. Margin-of-safety price. We have low confidence in the earnings level: two full years, one roughly $2 million and one roughly zero, from a business whose margin depends on Dutch bulb prices, the euro and crop health that it does not control, sold to four retailers who can replace a supplier. The worst plausible outcome, which the structure of the business does not protect against, is that the bank declines to refinance by mid-2027 while bulb payments peak and the shares are wiped out or heavily diluted; leased greenhouses and seasonal inventory give little hard asset backing. If we are wrong about the bulb-cost recovery or the price increase holding, the shares are worth nothing; if we are wrong in the other direction, about $3.40. The business pays no dividend and cannot under its loan agreement, so any return must come from the value of the shares. On today's facts no margin-of-safety price is supportable, because the middle outcome leaves nothing for shareholders. If the bank debt is refinanced on ordinary terms and the June 2027 year shows at least $3.5 million of cash before interest, the refinancing fees and penalty rates fall away, the base case moves to roughly break-even-plus and the bull case becomes a realistic one-in-four outcome; the margin-of-safety price would then be $0.50, a price from which reaching even one-third of the bull value within three years implies the required return, while the bear case implies a loss of the full price.